GeneDx Holdings (WGS) Equity Ratio (2020 - 2026)

GeneDx Holdings has disclosed Equity Ratio across 7 years of filings, most recently posting 0.5 for Q1 2026.

• In Q1 2026, Equity Ratio fell 12.95% year-over-year to 0.5; the TTM figure through Mar 2026 stood at 0.5 (down 12.95% YoY), while the FY2025 annual figure was 0.59, up 0.63% from the prior year.
• Equity Ratio slipped to 0.5 in Q1 2026, from 0.59 in the prior quarter.
• Over the last five years, Equity Ratio for WGS reached as high as 0.68 in Q2 2022 and fell as low as 0.5 in Q2 2024.
• The 5-year median for Equity Ratio is 0.59 (2025), against an average of 0.58.
• The widest YoY moves for Equity Ratio: up 126.74% in 2022, down 26.22% in 2022.
• A 5-year view of Equity Ratio shows it stood at 0.52 in 2022, then increased by 5.37% to 0.54 in 2023, then advanced by 7.4% to 0.58 in 2024, then rose by 0.63% to 0.59 in 2025, then declined by 14.71% to 0.5 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.5, 0.59, and 0.59 for Q1 2026, Q4 2025, and Q3 2025 respectively.